How to Buy Ultragenyx Pharmaceutical Stock
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally.
Ultragenyx Pharmaceutical stock last closed at $23.39, up 1.52% from the previous day, and has decreased 44.27% in one year. It has underperformed other stocks in the Biotechnology industry by 0.27 percentage points. Ultragenyx Pharmaceutical stock is currently +27.05% from its 52-week low of $18.41, and -45.88% from its 52-week high of $43.22.
At the moment, there are 96.63M shares of RARE outstanding. The market cap of RARE is $2.26B. In the past 24 hours, 1.38M RARE shares were traded.
How to Buy Ultragenyx Pharmaceutical Stock
Not sure how to invest in Ultragenyx Pharmaceutical stock? Here's how.
- Figure out where to buy Ultragenyx Pharmaceutical stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Ultragenyx Pharmaceutical stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your method of payment and add your information.
- Evaluate Ultragenyx Pharmaceutical stock: The Ultragenyx Pharmaceutical ticker symbol is RARE. Is Ultragenyx Pharmaceutical stock a good investment? Should you buy shares of RARE? How do RARE's underlying business fundamentals look? Do top analysts think Ultragenyx Pharmaceutical is a good buy? Why has RARE's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if RARE is a good stock to buy).
- Execute your RARE buy order: Decide if you will purchase RARE shares at the current market price or use a limit order to purchase RARE stock at a given price.
- Monitor your RARE investment: Create a watchlist to watch your investment in Ultragenyx Pharmaceutical shares.
Step 1: Figure out where to buy Ultragenyx Pharmaceutical stock
You need a brokerage account to access the NASDAQ market and buy RARE shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to invest in RARE today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have opened your account on a investment app, your next step is to transfer the money for your investment:
Watch the video below if you need help transferring funds into your investment account.
Step 4: Evaluate Ultragenyx Pharmaceutical stock
Once you have selected the best place to buy Ultragenyx Pharmaceutical stock, it's critical to analyze their stock before you buy, so you actually understand the risk as well as the opportunity.
Overview of key RARE info
Fundamentals of RARE
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on RARE's stock page.
What is the fair value of RARE stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge RARE's fair value.
You can do more valuation analysis on RARE's stock here.
A look at RARE Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the RARE balance sheet.
- RARE has cash burn of 472000000. It has sufficient cash and short-term investments to cover this for at least one year.
- RARE has $680.00M in cash and short term investments. This is sufficient to cover its annual cash burn of $472.00M.
Failed Financial Due Diligence Checks:
- Total RARE debt is still negative.
- RARE profit margin has gone up by 0.16 percentage points in the past year, but the company is still unprofitable.
- There are more long-term liabilities than short-term assets on the RARE balance sheet.
- RARE debt to equity ratio of -18.45 is negative.
Do Wall Street analysts think it's a good time to buy Ultragenyx Pharmaceutical stock
Out of 14 Wall Street analysts who monitor RARE, the consensus analyst rating on RARE is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent RARE Analyst Ratings
Tazeen Ahmad, a top 27% analyst from Bank of America maintains RARE with a strong buy rating and lowers their RARE price target from $72.00 to $58.00, on Jan 2, 2026.
Joseph Schwartz, a top 27% analyst from Leerink Partners maintains RARE with a buy rating and lowers their RARE price target from $80.00 to $70.00, on Dec 30, 2025.
Joel Beatty, a top 6% analyst from Baird maintains RARE with a buy rating and lowers their RARE price target from $72.00 to $47.00, on Dec 30, 2025.
Benjamin Burnett, a top 43% analyst from Wells Fargo maintains RARE with a strong buy rating and lowers their RARE price target from $65.00 to $45.00, on Dec 30, 2025.
Maury Raycroft, a bottom 4% analyst from Jefferies maintains RARE with a strong buy rating and lowers their RARE price target from $114.00 to $63.00, on Dec 30, 2025.
You can dig deeper into what analysts are forecasting on the Ultragenyx Pharmaceutical stock forecast page.
RARE Technical Indicators
RARE Revenue
Last year, RARE revenue was $673.00M. In the past 5 year, RARE's revenue has gone up by 19.95% per year. This was slower than the Biotechnology industry average of 32.76%.
You can research RARE's earnings and revenue performance here.
What are RARE executives and large shareholders up to?
In the past 12 months, executives and large shareholders at RARE have sold more shares than they have bought.
Howard Horn, Chief Financial Officer of RARE, was the latest RARE insider to sell. They sold $72,117.16 worth of RARE shares on Feb 2, 2026.
Research more about who owns RARE shares here.
Can I get consistent income from RARE stock?
No, Ultragenyx Pharmaceutical doesn't provide an income stream by paying out dividends.
What do other investors have to say about RARE?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your RARE buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Press the Open button and your broker will execute the order.
If you want additional help investing in stocks on eToro, watch the helpful video below:
Step 6: Monitor your RARE investment
Now that you own some RARE shares, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to see the latest developments about your RARE stock.
RARE Feed
How to Buy Stock in Ultragenyx Pharmaceutical
To reiterate, here are the 6 steps to buy stock in Ultragenyx Pharmaceutical:
- Figure out where to buy Ultragenyx Pharmaceutical stock
- Sign up for your brokerage account
- Deposit money your investment account
- Evaluate Ultragenyx Pharmaceutical stock
- Execute your RARE buy order
- Monitor your RARE investment
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep track of your new investment in Ultragenyx Pharmaceutical, create a watchlist today.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.